Doxycycline Capsules recalled over manufacturing violations
- Recall date
- March 13, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Sun Pharmaceutical Industries, Inc. recalls Doxycycline Capsules, USP, 100 mg, 50-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ…
- Recall number
- D-1033-2020
- FDA classification
- Class II
- Brand / firm
- Sun Pharmaceutical Industries, Inc.
- Sold / distributed
- Nationwide in the USA
Why it was recalled
CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Doxycycline Capsules, USP, 100 mg, 50-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-616-50.
Get recall alerts
Free email alert whenever Sun Pharmaceutical Industries, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Sun Pharmaceutical Industries, Inc.